Fund HoldingsB Group, Inc.

Total Portfolio Value
$134.89M
Total Bought
$43.63M
Total Sold
$1.36M
Net Transaction
+$42.26M
Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
PALISADE BIO INC4,500,00011,414,285+6,914,28510,57519,97514.81%+9,400
NRX PHARMACEUTICALS INC03,000,000+3,000,00006,3904.74%+6,390
BRIGHT MINDS BIOSCIENCES INC067,500+67,50004,9253.65%+4,925
SPYRE THERAPEUTICS INC(SYRE)100,000100,00003,2765,0443.74%+1,768
ZAI LAB LTD(ZLAB)400,000450,646+50,6467,0568,4776.28%+1,421
ORUKA THERAPEUTICS INC(ORKA)75,00075,00002,2733,6792.73%+1,406
IOVANCE BIOTHERAPEUTICS INC(IOVA)1,500,0001,500,00004,0955,2653.90%+1,170
PRAXIS PRECISION MEDICINES I(PRAX)33,23733,23709,79610,7097.94%+912
AURA BIOSCIENCES INC572,576597,576+25,0003,1213,9982.96%+877
FOGHORN THERAPEUTICS INC0102,000+102,00004880.36%+488
SOLENO THERAPEUTICS INC07,500+7,50002510.19%+251
REPLIMUNE GROUP INC(REPL)026,000+26,00001990.15%+199
STRUCTURE THERAPEUTICS INC90,000127,500+37,5006,2606,1464.56%-114
ULTRAGENYX PHARMACEUTICAL IN(RARE)135,000135,00003,1052,8282.10%-277
REPLIMUNE GROUP INC(REPL)(Call)50,0000-50,0004860-486
APOGEE THERAPEUTICS INC(APGE)20,0007,500-12,5001,5106310.47%-878
ASSEMBLY BIOSCIENCES INC175,706175,70605,9764,8763.61%-1,100
TAYSHA GENE THERAPIES INC(TSHA)1,800,5561,800,55609,9038,0485.97%-1,855
SIGHT SCIENCES INC920,000970,000+50,0007,2963,6572.71%-3,639
CELLECTIS S A3,281,5013,281,501015,88210,4027.71%-5,480
ADMA BIOLOGICS INC2,457,5423,207,542+750,00044,82628,90021.43%-15,926
Page 1 of 1